Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mach7 Technologies ( (AU:M7T) ) has provided an announcement.
Mach7 Technologies reported a positive operating cash flow in the second quarter of FY26 and maintained a strong debt-free balance sheet with A$18.5 million in cash, as it advances a strategic reset aimed at sustainable, profitable growth. Quarterly sales orders reached A$6.8 million, with 82% representing recurring revenue-type sales, and the company secured its first five-year subscription contract for its new Flamingo Architecture product, validating early market demand and supporting its repositioning “from archive to architecture.” Contracted Annual Recurring Revenue fell to A$26.1 million, down A$2.9 million mainly due to the Veterans Health Administration’s decision to discontinue its NextGen PACS program, but the ARR run rate remained stable at A$23.0 million as renewals and expansions offset these reductions. Management highlighted cost reductions from organisational restructuring and IT efficiencies, improved customer delivery and product ratings, and progress toward MDR compliance and CE Mark, positioning Mach7 for scalable growth and deeper penetration into global imaging markets despite the loss of the VHA-related revenue stream.
The most recent analyst rating on (AU:M7T) stock is a Hold with a A$0.41 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is an ASX-listed provider of innovative medical imaging software, including enterprise imaging platforms and viewing solutions such as its eUnity Viewer. The company focuses on enabling healthcare providers to manage, view and share imaging data more effectively, with a growing emphasis on its new Flamingo Architecture offering and expansion into regulated markets including Europe and the Middle East.
Average Trading Volume: 342,049
Technical Sentiment Signal: Sell
Current Market Cap: A$96.34M
Learn more about M7T stock on TipRanks’ Stock Analysis page.